Rofecoxib /ˌrɒfᵻˈkɒksɪb/ is a nonsteroidal anti-inflammatory drug (NSAID) that
has now been withdrawn over safety concerns. It was marketed by Merck ...
Rofecoxib (Vioxx) was withdrawn from the U.S. market in 2004. Rofecoxib is in a
class of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). Rofecoxib ...
Learn about drug side effects and interactions for the drug Vioxx (Rofecoxib).
Oct 20, 2015 ... Find a comprehensive guide to possible side effects when taking Vioxx (
Rofecoxib) for Professionals, Patients, and Caregivers.
Rofecoxib is used for the treatment of osteoarthritis, rheumatoid arthritis, acute
pain in adults, and primary dysmenorrhea, as well as acute treatment of migraine
Oct 16, 2004 ... Lessons from the withdrawal of rofecoxib. Patients would be safer if drug
companies disclosed adverse events before licensing. Paul A Dieppe ...
Original Article from The New England Journal of Medicine — Cardiovascular
Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention ...
Sep 30, 2004 ... Whitehouse Station, NJ - Merck has withdrawn its selective COX-2 inhibitor
rofecoxib (Vioxx<sup>®</sup>) from all markets worldwide, following the ...
Curr Med Res Opin. 2007 Aug;23(8):1859-66. Withdrawal of COX-2 selective
inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug ...
Rofecoxib is a synthetic, nonsteroidal derivative of phenyl-furanone with
antiinflammatory, antipyretic and analgesic properties and potential